The final gene set (GZMK, GZMA, IL7R, and ITGAL) was adapted into a gene score and applied to an independent cohort of treatment-naïve patients with stage-III ccRCC from the TCGA-KIRC cohort. This evidence concerns the gene IL7R and nonpapillary renal cell carcinoma.